Siglec-10 expression is up-regulated in activated human CD4⁺ T cells

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Most sialic acid-binding immunoglobulin-like lectins (Siglecs) are known to suppress immune cell activity.
• Siglecs are generally expressed at low levels on human T cells.
• The expression and function of Siglec-10 on human T cells, particularly in relation to CD52, remain debated.

Purpose of the Study:

• To investigate the expression of Siglec-10 at both RNA and protein levels in human CD4+ T cells.
• To determine if Siglec-10 is expressed on human T cells and its relationship with CD52.
• To explore the potential role of Siglec-10 in T cell function and homeostasis.

Main Methods:

• RNA sequencing (RNAseq) to analyze Siglec-10 gene expression.
• Quantitative Polymerase Chain Reaction (qPCR) for precise gene expression quantification.
• Flow cytometry to assess Siglec-10 protein expression on T cell surfaces.

Main Results:

• Siglec-10 expression was examined in human CD4+ T cells.
• RNAseq, qPCR, and flow cytometry confirmed Siglec-10 upregulation.
• Siglec-10 was selectively upregulated on a subset of activated CD4+ T cells that also showed high CD52 expression.

Conclusions:

• Siglec-10 is expressed on human CD4+ T cells, contrary to previous questions.
• The selective upregulation of Siglec-10 alongside CD52 suggests a specific regulatory function.
• These findings support a homeostatic role for Siglec-10 within human CD4+ T cell populations.